Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Clinical Immunology and Immunopathology
|
June 1, 1993
Chronic granulomatous disease: the solving of a clinical riddle at the molecular level
J T Curnutte
The Journal of Clinical Investigation
|
May 1, 1985
Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system
J T Curnutte
The Journal of Infectious Diseases
|
March 1, 1993
Conventional versus interferon-gamma therapy in chronic granulomatous disease
J T Curnutte
Hematology/Oncology Clinics of North America
|
June 1, 1988
Classification of chronic granulomatous disease
J T Curnutte
Immunodeficiency Reviews
|
January 1, 1992
Molecular basis of the autosomal recessive forms of chronic granulomatous disease
J T Curnutte
Blood
|
June 1, 1975
Effects of anaerobiosis and inhibitors on O2-production by human granulocytes
J T Curnutte, B M Babior
The Journal of Clinical Investigation
|
June 1, 1974
Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes
J T Curnutte, B M Babior
Advances in Human Genetics
|
January 1, 1987
Chronic granulomatous disease
J T Curnutte, B M Babior
Blood Reviews
|
December 1, 1987
Chronic granulomatous disease--pieces of a cellular and molecular puzzle
B M Babior, J T Curnutte
The Journal of Biological Chemistry
|
March 24, 1995
The cytosolic activating factors p47phox and p67phox have distinct roles in the regulation of electron flow in NADPH oxidase
A R Cross, J T Curnutte
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Clinical Immunology and Immunopathology
|
June 1, 1993
Chronic granulomatous disease: the solving of a clinical riddle at the molecular level
J T Curnutte
The Journal of Clinical Investigation
|
May 1, 1985
Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system
J T Curnutte
The Journal of Infectious Diseases
|
March 1, 1993
Conventional versus interferon-gamma therapy in chronic granulomatous disease
J T Curnutte
Hematology/Oncology Clinics of North America
|
June 1, 1988
Classification of chronic granulomatous disease
J T Curnutte
Immunodeficiency Reviews
|
January 1, 1992
Molecular basis of the autosomal recessive forms of chronic granulomatous disease
J T Curnutte
Blood
|
June 1, 1975
Effects of anaerobiosis and inhibitors on O2-production by human granulocytes
J T Curnutte, B M Babior
The Journal of Clinical Investigation
|
June 1, 1974
Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes
J T Curnutte, B M Babior
Advances in Human Genetics
|
January 1, 1987
Chronic granulomatous disease
J T Curnutte, B M Babior
Blood Reviews
|
December 1, 1987
Chronic granulomatous disease--pieces of a cellular and molecular puzzle
B M Babior, J T Curnutte
The Journal of Biological Chemistry
|
March 24, 1995
The cytosolic activating factors p47phox and p67phox have distinct roles in the regulation of electron flow in NADPH oxidase
A R Cross, J T Curnutte
Page
of 14